Liquid Biopsy
News and reporting on cell-free DNA testing.
BillionToOne Raises $55M in Series B Financing
The firm said the funding will help it pay for a recent laboratory expansion, growth of its commercial team, and new product development in the oncology space.
Genecast to Evaluate Liquid Biopsy EGFR Mutation Test in Early-Stage Non-Small Cell Lung Cancer
The firm hopes its qPCR-based liquid biopsy test could help identify early-stage NSCLC patients eligible for adjuvant or neoadjuvant anti-EGFR TKI treatment.
Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership
The complaint focuses on a recent patent filed by Chunxiao Song, the consultant, alleging that it falls within the terms of his contract with Bluestar.Â
Liquid Biopsy MRD Research at ASCO Showcases Uses in Variety of Tumor Types, Indications
Research presented at the ASCO meeting described efforts to expand the use of existing technologies into new directions.
New Liquid Biopsy Data at ASCO Highlights Commercial Push Into Early Cancer Detection
Cancer diagnostic firms showcased their discoveries as they flesh out their DNA methylation- and fragmentation-based platforms using circulating tumor DNA.